|
Immunology Product Line
Disorders of the immune system include the inability to make antibodies, imbalances in the system, or over-production of antibodies. Octapharma’s immunology portfolio provides a range of products that effectively treat such diseases and thus protect the patient from severe long-term health damage.
Click here to review general information about the indications for the Immunology Product Line.
 |
|
|
| octagam® - liquid, ready-to-use IVIG with a shelf life of up to 24 months at room temperature. Three validated manufacturing steps contribute to the virus safety of Octagam. Available in 1, 2.5, 5 and 10g formulations. |
|
|
|
|
|
 |
|
|
|
 |
|
|
| gammanorm® - virus inactivated immune globulin for subcutaneous (SCIG) and intramuscular use mainly in patients with primary and secondary immune deficiency. |
|
|
|
|
|
|
|
|
|
 |
|
|
rhesonativ® 625 IU
rhesonativ® 1250 IU
SD treated high titre anti-D immune globulin for prophylaxis of rhesus immunisation of Rh-negative women during pregnancy and delivery. Available in 625 IU (125 mcg) and 1250 IU (250 mcg) presentations. |
|
|
|
|
|
|
|
|
|
Octapharma has a very strong commitment to its immunology portfolio. We support and work closely with medical specialists of various fields, organizations such as the Jeffrey Modell Foundation, the Immune Deficiency Foundation, Neuropathy association and European Charcot Foundation. Through work with these organizations, Octapharma remains in touch with patient’s needs and at the forefront of research so that more patients world wide, may receive effective treatment based on our immunoglobulin products.
|
|
 |
|
Octapharma will sponsor two satellite symposia at the upcoming ISBT Congress, June 7 - 12, 2008 in Macau SAR, China
May 27, 2008
Octapharma at WFH Congress, June 1 - 5, 2008, Istanbul, Turkey
May 24, 2008
Octapharma acquisition of a plasma fractionation plant in Springe, Germany from German Red Cross organizations
May 8, 2008
|
|
|
|
